In October 2022, Illumina, Inc. and AstraZeneca formed a strategic research collaboration to expedite the discovery of therapeutic targets by combining their strengths in AI-based genome interpretation and genomic analysis tools with industry knowledge. The cooperation would assess if a framework made of both these technologies can boost target discovery yield and confidence in order to identify prospective therapeutics based on human omics insights.
Bioinformatics Market is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0%. according to a new report by MarketsandMarkets. The use of computer technology to comprehend and utilise biological and biomedical data effectively is known as bioinformatics.

Bioinformatics Market is projected to reach USD 18.7 billion by 2027, at a CAGR of 13.0%. according to a new report by MarketsandMarkets™. The use of computer technology to comprehend and utilise biological and biomedical data effectively is known as bioinformatics. It is the field responsible for storing, analysing, and interpreting the Big Data gathered during clinical settings or as a result of life science investigations. The growth of the bioinformatics market is driven by the increasing public and private-sector funding for bioinformatics, growing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure, and decreasing cost of genome sequencing. However, the high cost of equipment is hindering the growth of this market.

Download an Illustrative overview:

As the world witnesses unprecedented challenges in healthcare, from pandemics to personalized treatments, the role of bioinformatics has become more critical than ever before. [Your Company Name] has been at the forefront of harnessing the power of bioinformatics to unlock the potential of genomic data, enabling healthcare professionals, researchers, and pharmaceutical companies to make informed decisions and drive impactful outcomes.

Key Highlights and Innovations:

Advanced Genomic Analysis: MnM introduces cutting-edge algorithms and computational tools that empower researchers to extract valuable insights from complex genomic data.

Precision Medicine Solutions: Our state-of-the-art bioinformatics platforms enable healthcare providers to deliver personalized treatment plans based on a patient’s unique genetic makeup.

Drug Discovery Optimization: Leveraging artificial intelligence and machine learning, MnM has developed innovative approaches to streamline drug discovery pipelines.

Data Security and Privacy: In an era of data-driven healthcare, safeguarding sensitive genomic information is paramount. MnM employs state-of-the-art encryption and privacy protocols to ensure the security of patient data, fostering trust among patients, healthcare providers, and researchers.

Browse Complete Report @

Key Market Players

Some of the prominent players operating in the bioinformatics market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), DNASTAR (US), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.

Thermo Fisher Scientific, Inc. is the leading player in the bioinformatics market. The company mainly develops technologically advanced bioinformatics solutions to outstand its offerings. It invests into organic and inorganic growth strategies like acquisitions to strengthen its market presence.

North American bioinformatics market to dominate the market during the forecast period

North America dominated the bioinformatics market and is expected to grow at an 12.7% CAGR during the forecast period. The North America holds large share in the global bioinformatics market owing to factors such as government support for genomic research, presence of top key players in the region, reduced cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America.

Bioinformatics Market Dynamics:


1.  Increasing public-private sector funding for bioinformatics

2.  Increasing demand for personalized medicine

3.  Increasing pharmaceutical and biotechnology R&D expenditure

4.  Decreasing costs of genome sequencing


1.  High equipment costs


1.  Lucrative opportunities in emerging markets

2.  Adoption of blockchain technology and cloud computing

3.  Integration of machine learning and AI in healthcare

4.  Investments by leading IT companies in the development of bioinformatics solutions


1.  Management of large data volumes

2.  Lack of interoperability and multiplatform capabilities

3.  Growing competition from in-house development and publicly available tools

4.  Shortage of skilled bioinformatics professionals

Enquiry Before Buying:

Media Contact
Company Name: MarketsandMarkets Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.


Smart public opinion research for everyone.

%d bloggers like this: